FRG · Franchise Group, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $1.10B | - | $1.05B | $1.09B | $1.14B | - | $828.83M | $862.76M | $621.35M |
| Cost of Revenue | $632.62M | $669.11M | - | $616.48M | $612.25M | $628.11M | - | $497.35M | $283.79M | $342.82M |
| Gross Profit | $406.06M | $435.71M | - | $434.99M | $482.75M | $507.36M | - | $331.48M | $578.97M | $278.52M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $383.56M | $387.24M | - | $391.00M | $405.64M | $377.00M | - | $276.71M | $278.16M | $225.54M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | $22.50M | ($26.53M) | - | ($26.01M) | $77.11M | $130.37M | - | $54.76M | $58.16M | $52.98M |
| Interest Expense | - | - | - | - | - | - | - | $21.19M | $22.86M | $47.44M |
| Income Tax | ($13.85M) | ($7.17M) | - | $32.01M | $13.57M | $3.68M | - | ($15.52M) | $2.77M | ($2.85M) |
| Net Income | ($52.92M) | ($108.32M) | - | ($123.29M) | $38.85M | $12.32M | - | $164.07M | $38.74M | $13.81M |
| EPS - Basic | ($1.50) | ($3.16) | - | ($3.09) | $0.96 | $0.25 | - | $4.02 | $0.91 | $0.29 |
| EPS - Diluted | ($1.50) | ($3.16) | - | ($3.09) | $0.94 | $0.25 | - | $3.96 | $0.89 | $0.29 |
Balance Sheet
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $106.26M | $98.27M | $80.78M | $72.93M | $95.04M | $149.60M | $292.71M | $159.97M | $165.43M | $164.86M |
| Accounts Receivable | $256.00M | $151.72M | $170.16M | $143.24M | $178.69M | $110.37M | $118.70M | $95.69M | $81.08M | $88.26M |
| Inventory | $746.75M | $759.89M | $736.84M | $792.05M | $825.39M | $779.28M | $673.17M | $533.55M | $504.73M | $447.81M |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $1.34B | $1.34B | $1.32B | $1.39B | $1.48B | $1.66B | $1.48B | $807.85M | $886.46M | $861.61M |
| Total Assets | $3.57B | $3.61B | $3.63B | $3.67B | $3.82B | $3.85B | $3.91B | $2.83B | $2.89B | $2.86B |
| Current Liabilities | $975.96M | $1.06B | $943.91M | $1.01B | $968.04M | $1.17B | $1.12B | $554.37M | $585.12M | $591.56M |
| Long-term Debt | $1.53B | $1.39B | $1.37B | $1.29B | $1.28B | $1.29B | $1.38B | $1.07B | $1.25B | $1.24B |
| Total Liabilities | $3.35B | $3.33B | $3.21B | $3.12B | $3.05B | $3.10B | $3.15B | $2.19B | $2.40B | $2.40B |
| Stockholders' Equity | $225.43M | $277.65M | $421.38M | $545.76M | $768.85M | $751.69M | $762.83M | $639.48M | $488.00M | $463.46M |
| Retained Earnings | ($85.62M) | ($32.91M) | $109.92M | $134.42M | $282.35M | $270.61M | $286.99M | $167.63M | $21.17M | $19.0K |
Cash Flow
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | $19.69M | - | - | - | $62.15M | - | - | - | $115.77M |
| Investing Cash Flow | - | ($16.73M) | - | - | - | ($11.13M) | - | - | ($350.21M) | ($345.16M) |
| Financing Cash Flow | - | $14.43M | - | - | - | ($194.14M) | - | - | $409.55M | $338.17M |
| CapEx | - | - | - | - | - | - | - | - | $24.63M | $11.54M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | $104.23M |
Ratios
| Metric | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 39.1% | 39.4% | - | 41.4% | 44.1% | 44.7% | - | 40.0% | 67.1% | 44.8% |
| Operating margin | 2.2% | -2.4% | - | -2.5% | 7.0% | 11.5% | - | 6.6% | 6.7% | 8.5% |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | -5.1% | -9.8% | - | -11.7% | 3.5% | 1.1% | - | 19.8% | 4.5% | 2.2% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | 16.8% |
| FCF / Net income | - | - | - | - | - | - | - | - | - | 7.55 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 36.9% | 35.1% | - | 37.2% | 37.0% | 33.2% | - | 33.4% | 32.2% | 36.3% |
| Effective tax rate | - | - | - | - | 25.9% | 23.0% | - | -10.4% | 6.7% | -26.0% |
| Return on assets | -1.5% | -3.0% | - | -3.4% | 1.0% | 0.3% | - | 5.8% | 1.3% | 0.5% |
| Return on equity | -23.5% | -39.0% | - | -22.6% | 5.1% | 1.6% | - | 25.7% | 7.9% | 3.0% |
| Return on invested capital | 1.0% | -1.3% | - | -1.1% | 2.8% | 4.9% | - | 3.2% | 3.1% | 3.1% |
| Liquidity | ||||||||||
| Current ratio | 1.37 | 1.26 | 1.39 | 1.37 | 1.52 | 1.42 | 1.32 | 1.46 | 1.51 | 1.46 |
| Quick ratio | 0.60 | 0.54 | 0.61 | 0.59 | 0.67 | 0.75 | 0.72 | 0.49 | 0.65 | 0.70 |
| Cash ratio | 0.11 | 0.09 | 0.09 | 0.07 | 0.10 | 0.13 | 0.26 | 0.29 | 0.28 | 0.28 |
| Leverage | ||||||||||
| Debt / Equity | 6.77 | 5.02 | 3.26 | 2.36 | 1.67 | 1.71 | 1.81 | 1.68 | 2.55 | 2.68 |
| Debt / Assets | 0.43 | 0.39 | 0.38 | 0.35 | 0.34 | 0.33 | 0.35 | 0.38 | 0.43 | 0.43 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | 2.6x | 2.5x | 1.1x |
| Equity multiplier | 15.84 | 12.99 | 8.62 | 6.72 | 4.96 | 5.13 | 5.13 | 4.43 | 5.92 | 6.18 |
| Liabilities / Assets | 0.94 | 0.92 | 0.88 | 0.85 | 0.80 | 0.80 | 0.81 | 0.77 | 0.83 | 0.84 |
| Efficiency | ||||||||||
| Asset turnover | 0.29 | 0.31 | - | 0.29 | 0.29 | 0.29 | - | 0.29 | 0.30 | 0.22 |
| Inventory turnover | 0.85 | 0.88 | - | 0.78 | 0.74 | 0.81 | - | 0.93 | 0.56 | 0.77 |
| Days sales outstanding | 90d | 50d | - | 50d | 60d | 35d | - | 42d | 34d | 52d |
| Days inventory outstanding | 431d | 415d | - | 469d | 492d | 453d | - | 392d | 649d | 477d |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -5.1% | -2.7% | - | 26.9% | 26.9% | 82.7% | - | 4280.7% | 2264.6% | 7482.0% |
| Revenue CAGR (3y) | 205.3% | 412.8% | - | 217.4% | 444.7% | 441.2% | - | 158.0% | 380.6% | 323.4% |
| Revenue CAGR (5y) | 166.2% | 166.7% | - | 85.1% | 172.9% | 175.5% | - | 72.9% | 155.8% | 141.8% |
| Gross profit growth (YoY) | -15.9% | -14.1% | - | 31.2% | -16.6% | 82.2% | - | 2047.7% | 1486.8% | - |
| Operating income growth (YoY) | -70.8% | - | - | - | 32.6% | 146.1% | - | - | - | - |
| Net income growth (YoY) | - | - | - | - | 0.3% | -10.8% | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | 5.6% | -13.8% | - | - | - | -88.4% |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | 63.4% | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -70.7% | -63.1% | -44.8% | -14.7% | 57.6% | 62.2% | 98.1% | 56.5% | 67.9% | 50.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-25.
Business segments
$3.26B totalVitamin Shoppe$1.17B · 36.0%
American Freight$988.89M · 30.4%
Pet Supplies Plus$917.44M · 28.2%
Badcock$102.06M · 3.1%
Buddys$64.41M · 2.0%
Sylvan$9.68M · 0.3%
Product / service
$4.85B totalProduct$3.01B · 62.1%
Retail$1.17B · 24.2%
Wholesale$355.38M · 7.3%
Service$209.10M · 4.3%
Financial Service$41.62M · 0.9%
Rental$33.63M · 0.7%
Service Other$24.16M · 0.5%
Warranty Revenue$5.39M · 0.1%
Royaltiesand Advertising$262.0K · 0.0%
Interest$228.0K · 0.0%
Franchise$1.0K · 0.0%
Peer comparison
Same SIC group: Patent Owners & Lessors
Comparing Franchise Group against the 5 most active filers in the same SIC group.